Skip to content

CDC Solution: value indication

Line	Code	2024	2025	Change	%
Total assets	20/58	€1,565,788	€1,388,983	-€176,805	-11.3%
Fixed assets	21/28	€1,340,287	€1,282,092	-€58,195	-4.3%
Tangible fixed assets	22/27	€1,340,287	€1,282,092	-€58,195	-4.3%
Land and buildings	22	€1,340,287	€1,282,092	-€58,195	-4.3%
Current assets	29/58	€225,501	€106,892	-€118,610	-52.6%
Amounts receivable within one year	40/41	€217,834	€95,643	-€122,191	-56.1%
Trade receivables	40	€16,566	€18,997	+€2,432	+14.7%
Other amounts receivable	41	€201,268	€76,646	-€124,622	-61.9%
Cash at bank and in hand	54/58	€7,668	€11,249	+€3,581	+46.7%
Total equity and liabilities	10/49	€1,565,788	€1,388,983	-€176,805	-11.3%
Equity	10/15	€616,853	€664,455	+€47,602	+7.7%
Contributions	10/11	€18,592	€18,592	=	0.0%
Revaluation surpluses	12	€590,000	€590,000	=	0.0%
Reserves	13	€164,871	€145,825	-€19,046	-11.6%
Tax-exempt reserves	132	€164,871	€145,825	-€19,046	-11.6%
Profit (loss) carried forward	14	-€156,610	-€89,962	+€66,648	+42.6%
Provisions and deferred taxes	16	€65,586	€55,779	-€9,807	-15.0%
Deferred taxes	168	€65,586	€55,779	-€9,807	-15.0%
Amounts payable	17/49	€883,349	€668,749	-€214,600	-24.3%
Amounts payable after more than one year	17	€648,328	€553,864	-€94,464	-14.6%
Financial debts	170/4	€648,328	€553,864	-€94,464	-14.6%
Amounts payable within one year	42/48	€235,021	€114,885	-€120,136	-51.1%
Current portion of amounts payable after more than one year	42	€92,060	€94,460	+€2,399	+2.6%
Trade debts	44	€12,161	-	-€12,161
Suppliers	440/4	€12,161	-	-€12,161
Taxes, remuneration and social security	45	-	€20,425	+€20,425
Taxes	450/3	-	€20,425	+€20,425
Other amounts payable	47/48	€130,800	-	-€130,800
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets	630	€66,299	€58,195	-€8,104	-12.2%
Other operating charges	640/8	€12,995	€13,403	+€408	+3.1%
Gross operating margin	9900	€149,342	€148,072	-€1,270	-0.9%
Operating profit (loss)	9901	€70,047	€76,473	+€6,426	+9.2%
Financial charges	65/66B	€20,802	€18,253	-€2,549	-12.3%
Recurring financial charges	65	€20,802	€18,253	-€2,549	-12.3%
Profit (loss) for the period before taxes	9903	€49,246	€58,220	+€8,974	+18.2%
Transfer from deferred taxes	780	€9,807	€9,807	=	0.0%
Income taxes	67/77	-	€20,425	+€20,425
Profit (loss) for the period	9904	€59,053	€47,602	-€11,451	-19.4%
Transfer from tax-exempt reserves	789	€19,046	€19,046	=	0.0%
Profit (loss) for the period to be appropriated	9905	€78,098	€66,648	-€11,451	-14.7%

CDC Solution: value indication

CDC Solution: value indication

Position among the sector peers

What moved between 2024 and 2025

Largest movements

Change in the result, 2024 to 2025

Derived cash bridge

Value

Indicative value of the equity

Adjusted equity

Capitalised earnings

Your EBITDA multiple

Limits of the indication

Next steps